Assessment and Prediction of Cardiovascular Contributions to Severe Maternal Morbidity
Aarti Thakkar(Johns Hopkins University), Garima Sharma(Johns Hopkins University), Isabelle Malhamé, Sara Thorne(National Health Service), Rohan D’Souza(McMaster University), Minhal Makshood(Johns Hopkins University), Andreea A. Creanga(Centers for Disease Control and Prevention), Brent Gudenkauf(Houston Methodist), Afshan B. Hameed(University of California, Irvine), Sonia M. Grandi(University of Toronto)
Cited by 20
Related Papers
Pregnancy and contraception in heart disease and pulmonary arterial hypertension
|Journal of Family Planning and Reproductive Health Care|2006|179
Maternal Use of Opioids During Pregnancy and Congenital Malformations: A Systematic Review
|PEDIATRICS|2017|167
The role of screening, brief intervention, and referral to treatment in the perinatal period
|American Journal of Obstetrics and Gynecology|2016|160
Clinical care for opioid-using pregnant and postpartum women: the role of obstetric providers
|American Journal of Obstetrics and Gynecology|2013|118
SGLT2 Inhibitor Use and Risk of Clinical Events in Patients With Cancer Therapy–Related Cardiac Dysfunction
|JACC Heart Failure|2023|100